Sean Carrick - 29 Sep 2023 Form 4 Insider Report for Nascent Biotech Inc.

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Sean Carrick
Issuer symbol
NBIO on OTC
Transactions as of
29 Sep 2023
Net transactions value
+$346,575
Form type
4
Filing time
09 Nov 2023, 14:21:48 UTC
Previous filing
14 Jul 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $346,575 +2,772,600 +14% $0.1250* 22,469,707 29 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.